# VITO DIAGNOSTICS

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vito-diagnostics

- Industry: Healthcare
- Headquarters: Hangzhou, China
- Website: www.vitodx.com
- Latest round: Angel (Aug 17, 2021)
- Investors on record: 3

## About

Based in Hangzhou, China, and established in 2021, VITO DIAGNOSTICS is a medical diagnostic company whose business scope includes medical diagnostic services, also with the R&D and production of diagnostic reagents. The company has established third-party precision medicine testing laboratories in Beijing and Hangzhou and a research and development subsidiary in Australia. In May 2021, the company completed the B vitamin precision testing project and was recognized as Class B under the West Lake Talent Program. It also cooperated with healthcare service institutions such as Peking Union Medical College Hospital, Beijing Obstetrics and Gynecology Hospital, etc. In July 2024, VITO DIAGNOSTICS closed a strategic investment.

VITO DIAGNOSTICS engages in medical diagnostic services, R&D, and production of diagnostic reagents, focuses on reproductive health, birth defects, tumours, cardiovascular and cerebrovascular diseases, genetic metabolic diseases, and infectious diseases. The company has mass spectrometry detection devices for the comprehensive metabolism of red blood cells B vitamins. The test kits developed by VITO include a complete folate function test kit and a homocysteine ??test kit.

The company generates revenue by providing maternal-fetal medicine medical diagnosis, folic acid function testing and other services.

The company will focus on R&D investment, market expansion and other aspects.

## Funding rounds

- Angel, Aug 17, 2021 — HIIG Equity Fund, Hangzhou Xihu District Science and Technology Equity Investment, Westlake University Capital

## Investors

- HIIG Equity Fund (https://capitalatlas.ai/funds/hiig-equity-fund) — Angel
- Hangzhou Xihu District Science and Technology Equity Investment — Angel
- Westlake University Capital — Angel